
The research projects cover a broad range of topics and include both clinical and basic research. The early-career researchers are, among a range of other things, going to investigate:
– Some researchers will be enhancing our basic knowledge, whilst others will look into the development of concrete tools and treatments. We need both to enhance prevention, treatment and care of people living with diabetes and hormone-related diseases, says Chair of DDEA Board of Directors, Allan Flyvbjerg.
As something new, this call opened up for the opportunity to combine research and clinical work. This time, five of the postdoctoral fellowships were earmarked to part-time clinical research.
– Clinical research is often conducted by doctors. Once they have finished their first research project – their PhD – they often leave research to continue their clinical career fulltime. With our flexible clinical grants, they get the opportunity to continue their research and combine it with their clinical career. I believe this will make for more proficient researchers and doctors, and, ultimately, for better prevention, treatment and care of people with diabetes and hormone-related diseases, says Chair of DDEA Board of Directors, Allan Flyvbjerg.
The Academy aims to support early-career researchers within the fields of diabetes and hormone-related diseases through grants, education and networking activities.
DDEA is funded by the Novo Nordisk Foundation 2023 – 2027.

Chairman of DDEA Board of Directors Allan Flyvbjerg
Tel.: +45 5177 9548
Mail: allan.flyvbjerg1@outlook.dk

Managing Director Tore Christiansen
Tel.: +45 2964 6764
Mail: tore.christiansen@rsyd.dk
EAN: 5798 0022 30642
Reference: 1025 0006
CVR: 29 19 09 09